Related Experiment Videos
Expression of cyclooxygenase-2 (COX-2) mRNA in human colorectal adenomas
K Hasegawa1, W Ichikawa, T Fujita
1Second Department of Surgery, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. ku-ha@land.linkclub.or.jp
Abstract:
Cyclooxygenase-2 (COX-2) is an important target for the suppression of colorectal tumorigenesis by non-steroidal anti-inflammatory drugs (NSAIDs). To evaluate the role of COX-2 in human sporadic colorectal adenomas, COX-2 mRNA expression was examined by reverse transcription-polymerase chain reaction (RT-PCR) in 63 adenomas. COX-2 mRNA was detected in all the adenomas at higher levels than in normal colorectal mucosa (P<0.001). Levels of expression in the adenomas were correlated with their size (P=0.019), but no relationships were demonstrable between COX-2 expression and adenoma location, macroscopically observed configuration or microscopic degree of dysplasia. These findings suggest that COX-2 plays an important role in the growth of sporadic colorectal adenomas.
Insights
Cyclooxygenase-2 (COX-2) is elevated in colorectal adenomas, suggesting its crucial role in tumor growth. This finding supports COX-2 as a target for preventing colorectal cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Colorectal cancer remains a significant health concern, with adenomas being precancerous lesions.
- Non-steroidal anti-inflammatory drugs (NSAIDs) show potential in suppressing colorectal tumorigenesis, partly through targeting cyclooxygenase-2 (COX-2).
- Understanding the specific role of COX-2 in early-stage colorectal tumors like adenomas is crucial for developing targeted prevention strategies.
Purpose of the Study:
- To investigate the expression levels of COX-2 mRNA in human sporadic colorectal adenomas.
- To determine the correlation between COX-2 mRNA expression and adenoma characteristics such as size, location, and grade of dysplasia.
- To elucidate the functional significance of COX-2 in the development and growth of colorectal adenomas.
Main Methods:
- Analysis of COX-2 messenger RNA (mRNA) expression using reverse transcription-polymerase chain reaction (RT-PCR).
- Study cohort comprised 63 human sporadic colorectal adenomas and matched normal colorectal mucosa.
- Statistical analysis to correlate COX-2 expression levels with adenoma size, location, configuration, and degree of dysplasia.
Main Results:
- COX-2 mRNA was ubiquitously detected in all examined colorectal adenomas.
- COX-2 mRNA levels were significantly higher in adenomas compared to normal colorectal mucosa (P<0.001).
- A positive correlation was observed between COX-2 expression levels and adenoma size (P=0.019), but not with other examined features.
Conclusions:
- The consistent and elevated expression of COX-2 mRNA in colorectal adenomas highlights its involvement in tumor progression.
- COX-2 appears to play a significant role in the growth of sporadic colorectal adenomas.
- Targeting COX-2 may represent a viable therapeutic strategy for the prevention and treatment of colorectal adenomas and potentially colorectal cancer.